NCT00564681 - Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia | Biotech Hunter

Enrollment

242

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2009

Conditions

Cervical Dystonia

Interventions

BIOLOGICAL

botulinum toxin type A

Intramuscular injections into the affected muscles. Maximum dose of 360 units. Subjects may receive up to three treatments.

BIOLOGICAL

botulinum toxin type A Formulation 2

Intramuscular injections into the affected muscles. Maximum dose of 360 units. Subjects may receive up to three treatments.

DRUG

Normal Saline

Intramuscular injections of placebo (normal saline) into the affected muscles for treatment cycle 1.

Trial Locations (16)

Winston-Salem

Halifax

Prague

Berlin

Budapest

Mumbai

Manila

Warsaw

Moscow

Belgrade

Singapore

Spisska Nova

Cape Town

Tainan City

Bangkok

Bristol